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Abstract
Background: The modelling of gene regulation is a major challenge in biomedical research. This process is
dominated by transcription factors (TFs) and mutations in their binding sites (TFBSs) may cause the misregulation of
genes, eventually leading to disease. The consequences of DNA variants on TF binding are modelled in silico using
binding matrices, but it remains unclear whether these are capable of accurately representing in vivo binding.
In this study, we present a systematic comparison of binding models for 82 human TFs from three freely available
sources: JASPAR matrices, HT-SELEX-generated models and matrices derived from protein binding microarrays
(PBMs). We determined their ability to detect experimentally verified “real” in vivo TFBSs derived from ENCODE
ChIP-seq data. As negative controls we chose random downstream exonic sequences, which are unlikely to harbour
TFBS. All models were assessed by receiver operating characteristics (ROC) analysis.
Results: While the area-under-curve was low for most of the tested models with only 47 % reaching a score of 0.7
or higher, we noticed strong differences between the various position-specific scoring matrices with JASPAR and
HT-SELEX models showing higher success rates than PBM-derived models. In addition, we found that while TFBS
sequences showed a higher degree of conservation than randomly chosen sequences, there was a high variability
between individual TFBSs.
Conclusions: Our results show that only few of the matrix-based models used to predict potential TFBS are able to
reliably detect experimentally confirmed TFBS.
We compiled our findings in a freely accessible web application called ePOSSUM (http:/mutationtaster.charite.
de/ePOSSUM/) which uses a Bayes classifier to assess the impact of genetic alterations on TF binding in
user-defined sequences. Additionally, ePOSSUM provides information on the reliability of the prediction using
our test set of experimentally confirmed binding sites.
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Background
Transcription factors (TFs) are major players in the
regulation of gene activity. They bind to DNA target
sequences known as transcription factor binding sites
(TFBSs) in order to up- or down-regulate transcrip-
tional activity. As DNA binding is pivotal to correct
TF function, mutations in TFBSs can lead to genetic
disease [1, 2].
However, despite the rapid growth in the number of
mutations known to cause Mendelian disorders, the
number of confirmed mutations in regulatory sequences
is still low, presumably due to difficulties in experimen-
tally verifying their functional relevance as the cause of a
given disease.
With each deep sequencing run a large number of
DNA variants are found, many of which may be consid-
ered as potentially causing Mendelian disorders, even
after bioinformatic filtering. Hence the main challenge is
currently not the generation, but the interpretation of
the data. While considerable progress has been made at
the in silico analysis of alterations in the protein coding
sequences (e.g. MutationTaster [3], SIFT [4], PolyPhen-2
[5]), these prediction tools address the role of variants
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within potential regulatory sequences only indirectly, e.g.
via their evolutionary conservation, or the simple fact
that a variant occurred somewhere within a confirmed
regulatory element. We thus set out to examine and
compare the relevance of methods for computational
TFBS recognition as a means to assess the disease-
causing potential of genetic variants.
Currently, the state-of-the art method for functionally
representing TFBSs is via transcription factor binding
models that are described by matrices, such as position-
specific scoring matrices (PSSMs), also called position
weight matrices (PWMs). These PSSMs are normalised
representations of the position-specific log-likelihoods of
a nucleotide’s probability to occur at each location in an
observed sequence [6]. PSSMs can be used to computa-
tionally detect putative TFBSs in regulatory regions by
establishing a match score, which determines how well a
given sequence matches with a TF binding model.
A manually curated census in the year 2009 counted
1391 TFs in humans [7]. This number has grown since
then—estimates for the total number of human TFs cur-
rently range between 2000 and 3000 [7, 8]. However,
only a fraction of these factors have been studied in-
tensely enough to generate reliable binding models; the
ENCODE (Encyclopaedia of DNA Elements) project, for
example, offers one of the largest collections of experi-
mentally verified binding instances, but only covers 161
different TFs [9].
Moreover, various other repositories of TF binding
models exist that have been obtained by different
methods, but still fall short to represent the predicted
TF landscape in humans. The largest of these repositor-
ies, TRANSFAC [10], is not freely available and has
therefore not been included into this survey. The human
Protein-DNA Interactome (hPDI) [11] contains matrices
for 493 human TFs generated through Protein-Binding
Microarrays (PBMs), whereas a recent publication [12]
determined over 200 matrices for 151 human TFs via an
HT-SELEX experiment. HT-SELEX enables the identifi-
cation of DNA target strands through a large library of
artificially generated oligonucleotides, which are pre-
sented to a target protein. Bound sequences are ampli-
fied by PCR, followed by several rounds of selection
processes to determine the best-bound sequences. It is
not surprising that binding models derived from differ-
ent experimental methods can show highly different suc-
cess rates in modelling TF-DNA binding. However, for a
long time it was impossible to compare the quality of
binding models that had been obtained by various
methods due to the lack of sufficient experimental data.
Therefore, only recently a direct comparison between
TF models derived from PBM and HT-SELEX-
experiments has been published [13]. This study found
models generated through both experimental strategies
to be quite similar for in vitro binding, whereas for in
vivo prediction HT-SELEX-derived models achieved bet-
ter results.
Here we present a larger study in which we set out to
compare a total of 179 PSSMs linked to 82 different TFs
that derived from the following three sources: HT-
SELEX, PBM, and the manually curated binding models
provided by JASPAR [14]. Almost all of the 58 JASPAR
matrices (representing 56 TFs) used in our study re-
sulted from ChIP-seq experiments, only two, aimed at
NFIC and RELA, were generated by HT-SELEX experi-
ments. We tested all models for their capability to recog-
nise ChIP-seq confirmed functional (‘in vivo’) TFBSs
from the ENCODE project [15]. Due to the presence of
several TFs in more than one binding model source, we
were able to directly compare matrices linked to 26 dif-
ferent TFs from JASPAR and HT-SELEX, thereby enab-
ling a quality assessment of binding models obtained
through different experimental methods. For this study,
we created two test sets, one comprising all suitable
TFBSs from ENCODE and another one which includes
only those TFBSs with a high binding score (‘high-confi-
dence set’). We used the same number of length-
matched exonic sequences as a TFBS-depleted control
set.
This study is to our knowledge the largest comparison
of TF binding models, testing 179 binding models
(PSSMs) on over 2 x 2,000,000 target sequences in total.
Hence, our study provides insight into the current qual-
ity of computational TFBS predictions and the findings
generated in this study may help to evaluate the feasibil-
ity of whole-genome TFBS prediction studies.
Results and discussion
Binding predictions
We tested the PSSMs mentioned above and used ChIP-
seq derived sequences binding to TFs as positive con-
trols. Results were assessed with ROC analysis (see
Methods for details).
The various binding models from the multiple sources
yielded different results in many cases: While only 3 of
the 19 PBM-derived models from hPDI (16 %) reached
an AUC score of ≥0.7, this was the case for 46 % of the
HT-SELEX and 60 % of the JASPAR-models. The aver-
age AUC values generated by the different binding
model sources were highly divergent, ranging from 0.53
(hPDI) to 0.72 (JASPAR).
When tested on the ‘high-confidence’ dataset, 4 out
of 15 models (26.6 %) from hPDI yielded AUC scores
of ≥0.7, which resulted in an average AUC score of 0.57.
The HT-SELEX-models reached AUC values ≥0.7 in 70 %
of the cases (average AUC of all PSSMs: 0.76), whereas
the JASPAR-matrices generated an average AUC score of
0.83. An overview of these findings is depicted in Fig. 1.
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We were able to directly compare the prediction qual-
ity of models for 28 different TFs that were represented
in both the JASPAR and the HT-SELEX data (26 for the
high confidence test set). We found that in general, the
manually curated matrices from JASPAR enabled a
slightly better distinction between positive and negative
sequences (average AUC 0.74 versus 0.70). In the ‘high-
confidence’ data set, these values increased for both data
model sources: The HT-SELEX models generated an
average AUC of 0.80, whereas for JASPAR this value was
0.84 (Figs. 1a and 2).
These findings can help to estimate the utility of TFBS
models from different sources, enabling researchers to
better circumvent the high false-positive rate, a problem
which is well known for in silico TF binding analyses
[16], and thus to make the most of the available data. In
general, we found manually curated models provided by
JASPAR and HT-SELEX-derived matrices to be much
more successful in recognising in vivo TFBSs than PBM
derived models.
Previously, the success of TF binding prediction has
been found to be similar for the majority of matrices,
with degenerate matrices yielding the most accurate pre-
dictions [17]. Hence researchers currently often use TF
binding models from various sources indiscriminately.
The notion that TF binding models obtained through
different experimental methods can be variable has just
recently entered the scientific discourse in a novel publi-
cation [13]. There, the authors compared PBM- and HT-
SELEX-derived models and found both models to be
reliable with a slight advantage of HT-SELEX models in
the prediction of in vivo TFBSs. Our study on a larger
test set (up to several thousand binding events per TF
with direct comparison of models from different sources
for a subset of the tested TFs) showed JASPAR to be the
most reliable source for TFBS matrices in this data set.
Fig. 1 Average AUC scores and representative ROC plots for different binding model sources. a Average AUC scores generated for the different
binding model sources. b ROC plot for TFAP2C. c ROC plots for TFAP2A for the entire ENCODE test set (left) and the high confidence set (right).
d Underlying TF binding models for TFAP2A
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To check if the higher accuracy of JASPAR might
be the result of an overfitting of the JASPAR models
to the ENCODE data, we manually checked for an
overlap between the tested matrices and the ENCODE
data set. For each PSSM, we studied the accompany-
ing publication and found that this was not the case
for any of the binding models included in our study.
Hence we can safely assume that the current JASPAR
models are indeed the most successful ones to recog-
nise in vivo TFBSs.
In this study, we decided to use exonic sequences as a
negative test set. Because the 5’ regions of genes occa-
sionally contain functional binding sites [18, 19], we de-
cided to categorically exclude the first exon of each
transcript from our analyses. Thus, the percentage of
functional TFBSs in the negative test set should be suffi-
ciently decreased in order to allow computational pre-
dictions. We preferred this approach to alternative
analyses, such as the usage of artificially generated ran-
dom DNA sequences without TFBSs, as they might be
very different from naturally occurring sequences and
are also likely to increase error rates [20]. Furthermore,
the usage of random exonic sequences as a negative set
closely mimics the real-life research situation, therefore
allowing an important insight into the limitations of
current in silico TFBS analysis methods.
We found that the usage of only high-confidence EN-
CODE data leads to an increased reliability in the com-
puterised recognition of TFBSs. However, this filtering
step also introduces a potential drawback: Strong TF
binding does not necessarily implicate strong TF func-
tion, as has been shown for D. melanogaster [21], where
low-affinity binding sites can be of great importance for
normal gene activation. Moreover, a researcher looking
for a functional binding site in silico does not necessarily
have any previous knowledge on the binding strength.
Therefore, the decision to admit only high-confidence
data into analyses – which is common practice in TF
binding research [13, 17, 22]—in fact excludes a large
amount of relevant information and should therefore be
taken with care.
Conservation analyses
In a real-life research situation, TFBS predictions are
usually supplemented by additional analyses such as the
determination of sequence conservation. We therefore
further tested whether the ENCODE TFBSs (positive
set) show a higher degree of conservation than the
Fig. 2 Direct comparison of binding models generated by different methods. Depicted are AUC scores for TFs stored in both JASPAR (manually
collected curated models) and HT-SELEX. AUC scores were generated using ROCR. If multiple binding models were available for one TF, we depict
the average AUC value
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genetic background. In detail, we measured phyloP [23]
and phastCons [24] scores for each position of the EN-
CODE TFBSs and of negative test cases (length-matched
random sequences from chromosomes 1 and 2). For
each TF, we then calculated the average scores of the
highest conservation as well as of the average conserva-
tion score reported for each sequence. As we did not
know where exactly in the ENCODE sequence the actual
TFBS was located, we chose to focus on the highest con-
servation scores, assuming that functional TFBSs would
show a high degree of conservation. However, we found
that, while there was a higher degree of conservation for
the ENCODE sequences, the variability in the tested se-
quences was very high. Moreover, we did not find a link
between strong TF binding and sequence conservation
because the mean maximum phyloP and phastCons
scores for the high-confidence test set were not signifi-
cantly higher than for all ENCODE sequences. We
hence conclude that, while this may sometimes be the
case, a functional binding site does not necessarily have
to be highly conserved. As a representative example,
Fig. 3 shows example images of conservation readings
for ZBTB33 and BCL11A.
Our findings indicate that while there seems to be a
certain degree of increased conservation for ChIP-seq
verified TFBSs in comparison to random genetic se-
quences (Fig. 3), the variability between individual
sites is too high to draw any reliable conclusions.
These results support previous findings, which suggest
that functional TFBSs can, but do not have to be evo-
lutionarily conserved with regard to their primary nu-
cleotide sequence [25–27]. More precisely, some
researchers argue that TFBSs may fluctuate quite rap-
idly between species. For instance, it has been found
in a comparative genomics study that the likelihood
of a TFBS to be conserved between S. cerevisiae and
its two closest relatives (S. paradoxus and S. mikatae)
lies below 5 % for a majority of the sites [26]. In
addition, rapid evolution of combinatorial transcrip-
tion networks was found for the transcriptional regu-
lator MCM1 in closely related fungi species [28].
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Fig. 3 Representative plots for conservation analyses. We determined the maximum phastCons (a) and phyloP (b) scores in each experimentally
confirmed binding site of BCL11A (left panel) and ZBTB33 (right panel) and calculated the averages of the maximum scores
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introducing local point mutations showed TFBSs and
combinations of binding sites to evolve quickly [29].
Considering the fact that TFBSs are known to be
relatively variable, even within the same species, it
would be surprising if all functional binding sites
were conserved across larger evolutionary distances
[27, 30, 31]. It has also been shown in comparative
studies between various species that the functionality
of TFBSs can still be preserved despite underlying se-
quence changes [32, 33]. The three-dimensional struc-
ture of the DNA at a TFBS, including the histones, is
likely to play an important role for TF binding, a no-
tion which is slowly being acknowledged for the ana-
lysis of TFBSs [34]. As such three-dimensional
structures can be well conserved while the underlying
linear sequence may evolve rapidly, sequence conser-
vation scores might not be of major importance for
the assessment of TFBSs. In our study, we found that
the degree of variation between individual TFBSs was
too high to infer TFBSs conservation in general.
Hence, measurements such as genomic location or
three-dimensional conservation might be better suited
for the assessment of the validity of a TFBS.
Regulatory SNPs (rSNPs)
We compiled a set of 52 rSNPs known to directly
impact TF binding or gene expression (included as
Additional file 1). rSNPs are single-nucleotide poly-
morphisms occurring in regulatory regions such as
promoters or enhancers. They are likely to be of
functional significance as they do affect transcription
initiation, elongation, and translational characteristics
of mRNA but are more difficult to study than alter-
ations in coding regions and are hence under-
represented in the literature [35–37]. We only
included alterations in this test set which have been
shown to directly interfere with a TFBS’s function in
in vitro or in vivo experiments. In this test set, we
found differences between wild-type and mutant vari-
ants with respect to the evaluated maximum binding
scores in 76 % of all observations, but they rarely
exceeded 20 %. For a subset of the rSNPs, which
linked to 15 different TFs (represented by 58 PSSMs
from JASPAR, hPDI, and HT-SELEX), we were able
to directly compare the computational predictions to
the experimental findings. If solely considering max-
imum binding score changes, we found agreement be-
tween computational and experimental results in less
than 50 % (48.1 %) of the tested matrices. However,
when analysing the data with ePOSSUM (see below),
we obtained a correct prediction in 62 % of the cases.
Interestingly, the different binding models from the
various sources again yielded quite divergent results,
thus confirming strong variability in the quality of the
tested matrices (see Additional file 1).
We are aware that the rSNP test set used in this study
was not large enough to provide comprehensive insight.
This is due to the fact that experimental data on rSNPs
in TFBSs are not readily available. Hence, we decided to
make the best of the available data and to provide an ini-
tial glimpse into the reliability of the state-of-the-art
methods for TFBS prediction.
ePOSSUM
Our study demonstrates that many of the existing
PSSMs offer only limited reliability, while others do in-
deed allow reasonable predictions. In order to make our
findings readily available to the scientific community, we
created software called ePOSSUM that predicts the ef-
fect of genetic variation on TF binding using the matri-
ces included in our study. It also includes a measure of
significance of the assessments to indicate how reliable a
prediction by a certain PSSM would be.
ePOSSUM is a web-based application that can be
freely accessed at http://mutationtaster.charite.de/ePOS-
SUM/. Users can either enter genetic variants in the
common VCF format or wild-type sequences along with
the variant sequences. In the first case, the position of
the variant is known and ePOSSUM scans the ENCODE
ChIP-seq data used in our study for known TFBSs
around this position. The existence of TFBSs at the pos-
ition under study is included in the output. In total,
ePOSSUM offers predictions for 81 TFs which are based
on 171 different PSSMs. To speed up analysis, users can
choose which TFs to include into the search for binding
sites. If they submit a genomic position, they can limit
the search to those TFs that are known to bind at this
position.
Unlike similar applications such as motifbreakR [38],
ePOSSUM does not merely subject sequences to differ-
ent PSSMs, but uses their binding scores as input for a
Bayes classifier. More precisely, this classifier uses the
quotient of the maximum binding scores calculated for
wild-type and variant sequence to determine whether
the genetic alteration leads to the (predicted) gain or loss
of a TFBS. As most of these quotients do not show a
normal distribution, we use the R module klaR [39] for
the classifier, which considers the kernel-density, i.e. the
real distribution of values, to generate predictions.
Due to the poor performance of many PSSMs in dis-
criminating real TFBSs from exonic sequences as indi-
cated by similar maximum binding scores for both, the
Bayes probability for both outcomes (TF binding versus
no TF binding) is often far from 100 %. We therefore in-
clude the negative or positive predictive value (NPV/
PPV) for each matrix for the given Bayes probability as a
measure of the reliability of the classifier’s prediction.
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This value is also used to colour-code the likelihood of
increased/new or decreased/lost TF binding. Darker col-
ours represent more likely changes in TF binding. ePOS-
SUM uses all available PSSMs for a TF to generate a
final assessment—here, only PPVs/NPVs of 70 % or
above are considered. The assessment also includes
whether or not a binding site for the TF was reported by
ENCODE at the respective genomic location.
Different Bayes classifiers were trained for each PSSM
with the quotients of all possible pairs of positive versus
negative cases for the respective TF using all available
sequences from our ENCODE high-confidence set as
positive and exonic sequences as negative cases. The
number of pairs was deliberately limited to 1,000,000
per matrix, even if more pairs were possible.
ePOSSUM is limited to human TFs and, if genomic
positions were used, to genome version GRCh37. A
weakness lies in the recognition of known TFBSs—as
each TFBS positive ChIP-seq snippet from ENCODE
comprises several hundred bases, we do not know
whether or not the “real” TFBS is truly located within
the fragment screened in the analysis.
Conclusions
The assessment of variation in regulatory sequences re-
mains a substantial challenge for the research commu-
nity. While in previous decades genetic analyses focused
on protein-coding regions, due to the availability of deep
sequencing the search for regulatory mutations has
meanwhile become a research focus. The properties of
TF binding have been investigated for a long time and
therefore offer a myriad of data for computational ana-
lyses. However, the utility of TF binding models for
large-scale TFBS recognition has not been extensively in-
vestigated yet.
Therefore, this study is an attempt at comparing the
accuracy of TF matrices obtained by various experimen-
tal methods in predicting functional TFBSs on a large
scale. Thus, it enables an analysis of the quality and rele-
vance of current TF binding prediction data.
Problems in predicting TFBSs in silico include high
false-positive rates [16] high variability [30, 40], and in-
sufficient knowledge of the exact in vivo binding sites
[17, 41]. Current TF binding models are usually based
on mere one-dimensional sequence parameters, which
poses a major limitation.
To tackle these problems, researchers have to wisely
choose data sources as well as TFBS predictors. Taken
together, our analysis and the newly created and free-to-
use software ePOSSUM provide previously unknown
quality measures for computational TFBS predictions
thus enabling researchers to extract and use the most
meaningful of the available data.
Methods
TF binding models
TF binding matrices generated via three different experi-
mental methodologies were obtained from the R package
MotifDb [42]. This tool contains a large and up-to-date
collection of freely available TF binding models. We
used human PSSMs from some of the largest and most
frequently used ‘open source’ TFBS data sources: hPDI
(19 matrices), JASPAR (58 matrices linked with 56 dif-
ferent transcription factors), and HT-SELEX studies (102
matrices linked with 47 different factors). For hPDI and
JASPAR, usually one matrix was available per TF,
whereas the HT-SELEX data reported up to six variants
per TFs. The tested PSSMs were highly variable, ranging
from approximately 5 to 19 bp length, with hPDI-
matrices being generally shorter than models obtained
from the other two sources. In this study, in order to ob-
tain comparable results, we only evaluated monomeric
binding models, despite the fact that the latest issue of
JASPAR also contains a number of homodimeric
models. An overview of the binding models can be
found in Fig. 4 and in the Additional file 2.
Fig. 4 Overview of tested TFs for the entire data set (a) and the high-confidence data (b). ENCODE: Entire set of ENCODE TFBSs (2012 freeze).
High confidence set: TFs reaching at least 80 % of the maximum possible binding score (published by ENCODE) in at least 100 binding instances.
Please note that the intersections are not drawn to scale
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Experimentally confirmed TFBSs (positive cases)
The positive test set consisted of ChIP-seq confirmed
TF binding events, which were obtained from the EN-
CODE project [9] (March 2012 Freeze), as provided by
the UCSC [43]. This data includes TF binding instances
found in ChIP-seq experiments that had been performed
on various human cell lines. For each binding event, the
genomic location is reported together with a binding
score indicating the strength of the protein-DNA
interaction.
High-confidence positive test set
In the first step of the experiment, all reported ChIP-seq
instances were incorporated into the workflow. In a sec-
ond approach, only sequences reaching at least 80 % of
the maximum possible binding score published by EN-
CODE were included into a ‘high-confidence’ test set. Of
these cases, we only tested TFs for which at least 100
binding instances were reported by ENCODE to reach
this threshold. Hence, 15, 44, and 55 TFs remained for
hPDI, HT-SELEX and JASPAR, respectively.
TFBS-depleted DNA (negative test set)
For the negative test set, we used exonic sequences
(GRCh37) which we obtained via Ensembl-Biomart [44].
For each sequence of the positive test set, we randomly
selected an exonic sequence of equal or greater length to
the corresponding TFBS sequence; in case of longer ex-
onic sequences, these were shortened randomly to
match the TFBS sequence. We routinely omitted the
first exon of each transcript in order to decrease the
chance of erroneously including TFBSs located down-
stream of the transcription start site [18, 19].
Binding predictions
We applied each PSSM included in this study to the re-
spective ENCODE sequences and their length-matched
exonic negative controls. In total, we tested 179 models
that were linked with 82 different TFs on over 4,000,000
positive and negative sequences.
Binding of a TF to a target sequence was determined
using R and the Biostrings [45] function matchPWM
(see Implementation). MatchPWM is a simple matching
algorithm, which takes a DNA target sequence and a
PWM (PSSM) of interest as inputs and computationally
determines a match score. Each PWM has a theoretical
maximum PWM score, which can be obtained by sum-
ming up the strongest weights. For each position of the
target sequence, matchPWM compares the match score
with the maximum score of the model and reports each
hit above a user-defined threshold, which we set to 20 %
in order to also detect ‘weak’ binding site predictions.
For each of the positive and negative test set entries, we
then conducted scans of both the forward and the
reverse strand and determined the maximum score
found within the respective pair of forward/reverse se-
quences. For each matched pair we thus obtained two
scores, one for the true TFBS case and one for its con-
trol sequence.
The binding models in MotifDb are stored in position
frequency matrices, where each column sums up to 1.
MatchPWM, however, expects a position weight matrix
or a position count matrix with column sums different
to 1. To work around this problem, we multiplied each
matrix field by the scaling factor of 100 to obtain matri-
ces of the desired scale. As the sequences in the positive
test set have been experimentally shown by the EN-
CODE project to contain functional TFBSs, they were
expected to yield a significantly higher ratio of high
match scores than their negative counterparts.
We then applied receiver operating characteristic
(ROC) analyses as provided by the R package ROCR
[46] to test the discriminative power of score
assignments.
Conservation analyses
Conservation scores for the three different groups of
test sequences (ENCODE sequences, ENCODE high-
confidence set, random length-matched control se-
quences) were generated using phyloP [23] and phastCons
[24]. For these analyses, we obtained conservation scoring
files for multiple alignments of 45 vertebrate genomes to
the human genome (‘46 way’) from the UCSC PHAST
package [47]. As exonic sequences are expected to be
highly conserved, the negative test set for TF binding (ex-
onic sequences, exon 1 omitted) could not be used for this
analysis. Therefore, we generated a data set of random se-
quences by picking random genomic positions on chro-
mosomes 1 and 2 and length-matching the sequences to
ENCODE TFBS snippets.
Regulatory SNPs (rSNPs)
As a proof of concept, we tested some of the available
binding models on a small test set of 52 experimentally
verified regulatory single nucleotide polymorphisms
(rSNPs) that were reported in the literature. For these
rSNPs the effect of the alteration on TF binding and/or
gene regulation had been determined experimentally in
wet-lab experiments. We collected relevant rSNP posi-
tions through an extensive literature research and then
tested the corresponding binding models on a DNA se-
quence snippet spanning 20 bp 3’ and 5’ of the respect-
ive rSNP. Repositories or collections of verified
alterations in TFBSs were found in a limited number of
publications [40, 48–50], while other data was compiled
manually from the literature. A summary of the rSNP
test set listing the individual publications for each of the
tested variants can be found in the Additional file 1.
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Implementation
TFBS prediction
We used R version 3.1.0 and the Bioconductor suite 3.1
[51]. For the determination of TFBSs, we applied Bio-
strings version 2.36 [45]. In this study, we used the func-
tion matchPWM to match the PSSMs against target
sequences. Human PSSMs were obtained from MotifDb
version 1.10.0 [42] ROC plots were created with the R
module ROCR (version 1.0-5) [46] which we also used
to determine the area-under-curve (AUC) scores.
ePOSSUM
ePOSSUM is web-based and consists of a Perl/CGI en-
velope for R scripts. We employ a PostgreSQL database
to screen genomic positions for TFBSs reported by the
ENCODE project. The R code uses the same packages
as described above and the klaR module [39] which pro-
vides a kernel-density based Bayes classifier.
The connection between Perl and R is handled by the
Statistics::R module.
Additional files
Additional file 1: Test set of 52 rSNPs known to directly impact TF
binding or gene expression. (XLS 13 kb)
Additional file 2: Overview of tested binding models. (TXT 236 kb)
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